EUVIMEDEUVIMED entdecken
Crossref

Everolimus: Emerging Evidence of its Therapeutic Impact in Patients with Advanced Renal Cell Carcinoma

Daniel C. Cho and Michael B. Atkins

Clinical Medicine Reviews in Oncology · 2010

DOI: 10.4137/cmro.s3428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Verfasst von Daniel C. Cho and Michael B. Atkins.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Atkins, D. C. C. A. M. B. (2010). Everolimus: Emerging Evidence of its Therapeutic Impact in Patients with Advanced Renal Cell Carcinoma. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s3428

Vancouver

Atkins DCCAMB. Everolimus: Emerging Evidence of its Therapeutic Impact in Patients with Advanced Renal Cell Carcinoma. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s3428

BibTeX
@article{Atkins2010,
  author = {Atkins, Daniel C. Cho and Michael B.},
  title = {Everolimus: Emerging Evidence of its Therapeutic Impact in Patients with Advanced Renal Cell Carcinoma},
  journal = {Clinical Medicine Reviews in Oncology},
  year = {2010},
  doi = {10.4137/cmro.s3428}
}
Kostenlos starten →